Trial Profile
A retrospective study of Lutonix 035 Drug Coated Balloon (DCB) and In.Pact DCBs in patients with symptomatic peripheral artery disease undergoing femoropopliteal intervention.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Feb 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Therapeutic Use
- 12 Feb 2016 New trial record
- 09 Feb 2016 According to a Bard Peripheral Vascular Inc. media release results of retrospective study of Lutonix 035 Drug Coated Balloon (DCB) and In.Pact DCBs in patients with symptomatic peripheral artery disease undergoing were presented at Leipzig International Course (LINC).
- 09 Feb 2016 Results published in the Bard Peripheral Vascular Inc. media release.